Cleared Special

QUANTIX/OR BLOOD FLOW MONITOR (K050088) - FDA 510(k) Clearance

Also marketed or referenced as:
FLEXIBLE PROBE WITH OPTIONAL VESSEL STABILIZER

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K050088 · Neoprobe Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2005
Decision
26d
Days
Class 2
Risk

K050088 is an FDA 510(k) clearance for the QUANTIX/OR BLOOD FLOW MONITOR. Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.

Submitted by Neoprobe Corp. (Dublin, US). The FDA issued a Cleared decision on February 8, 2005 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Neoprobe Corp. devices

Submission Details

510(k) Number K050088 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 13, 2005
Decision Date February 08, 2005
Days to Decision 26 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
99d faster than avg
Panel avg: 125d · This submission: 26d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DPW Flowmeter, Blood, Cardiovascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPW Flowmeter, Blood, Cardiovascular

All 24
Devices cleared under the same product code (DPW) and FDA review panel - the closest regulatory comparables to K050088.
FlowMet-R
K182494 · Laser Associated Sciences, Inc. · Feb 2019
iCertainty
K181269 · Rfpi · Dec 2018
Deltex Medical CardioQ-EDM+, Deltex Medical CardioQ-EDM
K172457 · Deltex Medical Limited · Jun 2018
MODEL 7700A/77010A/77025A/77030A/77035A ULTRA IMAG
K913827 · Hewlett-Packard Co. · Nov 1991
MODIFIED SOFTWARE TO THE SONOS 100 ULTRASOUND
K902088 · Hewlett-Packard Co. · Aug 1990
NKA MODEL MFV-3100 & MFV-3200 ELECTRO. BLOOD FLOW.
K894631 · Nihon Kohden America, Inc. · Jan 1990